(R)-3-(5-C◦hloro-1H-indol-3-yl)-1,3-diphenylpropan-1-one (4d).
Mp 165–166 C; [a]2D4 -35 (c 0.50, CHCl3, 90% ee); Rf 0.15 (hexane:
ethyl acetate = 5 : 1) 1H NMR (400 MHz, CDCl3) d = 8.00 (brs, 1
H), 7.94–7.92 (m, 2 H), 7.55 (dddd, 1 H, J = 7.5, 7.3, 1.3, 1.3 Hz),
7.44 (dd, 2 H, J = 7.7, 7.5 Hz), 7.38 (d, 1 H, J = 2.0 Hz), 7.33 (m, 2
H), 7.29–7.25 (m, 2 H), 7.23 (d, 1 H, J = 8.6 Hz), 7.18 (dddd, 1 H,
J = 7.3, 7.1, 1.3, 1.3 Hz), 7.09 (dd, 1 H, J = 8.6, 2.0 Hz), 7.04 (d, 1
H, J = 2.4 Hz), 5.00 (dd, 1 H, J = 7.3, 7.1 Hz), 3.78 (dd, 1 H, J =
16.7, 7.3 Hz), 3.70 (dd, 1 H, J = 16.7, 7.1 Hz). 13C NMR (100 MHz,
CDCl3) d = 198.3, 143.8, 137.0, 134.9, 133.1, 128.6, 128.6, 128.1,
127.8, 127.7, 126.5, 125.2, 122.7, 122.5, 119.1, 119.0, 112.1, 45.2,
38.0. IR (CHCl3) 3477, 1686, 1599, 1464, 1448, 1377, 1362, 1223,
1209, 1101 cm-1; MS (EI) m/z 361 (M++1, 8), 359 (M+-1, 26), 284
(2), 254 (18), 242 (32), 240 (100), 204 (17), 176 (5), 151 (3), 105
(17), 77 (16), 69 (9).; Found: C, 76.87; H, 4.82; N, 3.87%. Calcd for
C23H18ClNO: C, 76.77; H, 5.04; N, 3.89%; HPLC: Daicel Chiralcel
OD-H, Hexane/EtOH = 10/1. Flow rate = 1.0 mL min-1, UV =
254 nm, tR = 19.5 min (major), tR = 24.4 min (minor).
dihydroindole 5 (23.8 mg, 0.2 mmol) was added. After being
stirred at the temperature for 48 h, the mixture was quenched with
NaHCO3, and extracted with AcOEt(¥3). The combined organic
layers were washed with brine, dried over anhydrous Na2SO4, and
concentrated under vacuo to dryness. The residue was purified by
p-TLC (hexane–ethyl acetate = 5/1) to obtain 6a as yellow solid.
This material was subjected to RuZrP oxidation (25 mg, 5 mol%
against 5) under O2 at 80 ◦C in toluene. As a result, corresponding
adduct 7a was obtained with high yield and good ee.
Mp 136–137 ◦C (i-PrOH); [a]D26 -50 (c 1.0, CHCl3, 87% ee); Rf
1
0.40 (hexane: ethyl acetate = 5 : 1), H NMR(400 MHz, CDCl3)
d = 8.23 (brs, 1 H), 7.99–7.97 (m, 2 H), 7.58 (dddd, 1 H, J = 7.5,
7.3, 1.8, 1.3 Hz), 7.50–7.45 (m, 3 H), 7.36–7.31 (m, 4 H), 7.29–
7.24 (m, 2 H), 7.10 (ddd, 1 H, J = 7.1, 7.1, 1.1 Hz), 7.03 (ddd,
1 H, J = 7.1, 7.1, 1.1 Hz), 6.19 (m, 1 H), 4.95 (dd, 1 H, J = 8.2,
5.3 Hz), 3.93 (dd, 1 H, J = 17.6, 8.2 Hz), 3.68 (dd, 1 H, J = 17.6,
8.2 Hz). 13C NMR (100 MHz, CDCl3) d = 198.5, 142.2, 141.5,
136.6, 136.0, 133.3, 128.6, 128.6, 128.1, 128.0, 128.0, 127.0, 121.3,
119.9, 119.5, 110.6, 99.7, 44.7, 39.6. HPLC: Daicel Chiralpak AS-
H, Hexane/iPrOH = 9/1. Flow rate = 1.0 mL min-1, UV = 254 nm,
tR = 13.9 min (major), tR = 16.3 min (minor).
(R)-3-(4-Fluorophenyl)-3-(1H-indol-3-yl)-1-phenylpropan-1-one
(4k). Mp 149–150 ◦C; [a]D27 -43 (c 1.0, CHCl3, 90% ee); Rf 0.10
1
(hexane: ethyl acetate = 5 : 1), H NMR (400 MHz, CDCl3) d =
7.99 (brs, 1 H), 7.94–7.91 (m, 2 H), 7.55 (dddd, 1 H, J = 7.5, 7.3,
1.3, 1.3 Hz), 7.44 (dd, 2 H, J = 7.9, 7.3 Hz), 7.40 (d, 1 H, J =
7.9 Hz), 7.34 (ddd, 1 H, J = 8.2, 0.9, 0.7 Hz), 7.30 (dd, 2 H, J =
8.6 Hz, JH–F = 5.5 Hz), 7.16 (ddd, 1 H, J = 7.1, 6.9, 1.1 Hz), 7.03
(ddd, 1 H, J = 7.1, 7.0, 1.1 Hz), 7.00 (d, 1 H, J = 2.2 Hz), 6.93
(dd, 2 H, JH–F = 8.8, 8.6 Hz), 5.05 (dd, 1 H, J = 6.4, 8.1 Hz), 3.80
(dd, 1 H, J = 16.7, 6.4 Hz), 3.70 (dd, 1 H, J = 16.7, 8.1 Hz).;
19F-NMR (376 MHz, CDCl3) d = 44.8 (m).; 13C NMR (100 MHz,
CDCl3) d = 198.4, 161.3 (d, J = 244.4 Hz), 139.9, 139.8, 137.0,
136.6, 133.1, 129.2 (d, J = 7.7 Hz), 128.6, 128.0, 126.4, 122.2,
121.3, 119.4 (d, J = 4.6 Hz), 119.2, 115.1 (d, J = 21.1 Hz), 111.2,
45.2, 37.5. IR (CHCl3) 3479, 3010, 1684, 1599, 1508, 1456, 1448,
1337, 1229, 1157, 1096, 1014 cm-1; MS (EI) m/z 343 (M+, 18),
238 (13), 224 (100), 97 (11), 83 (18), 69 (23).; Found: C, 80.23;
H, 5.36; N, 3.81%. Calcd for C23H18FNO: C, 80.45; H, 5.28; N,
4.08%; HPLC: Daicel Chiralpak AD-H, Hexane/EtOH = 1/1.
Flow rate = 0.5 mL min-1, UV = 254 nm, tR = 12.4 min (major), tR =
13.8 min (minor).
(S)-3-(4-Chloroph◦enyl)-3-(1H-indol-2-yl)-1-phenylpropan-1-one
(7b). Mp 122–123 C; [a]D25 -8.0 (c 1.0, CHCl3, 84% ee); Rf 0.25
(hexane: ethyl acetate = 5 : 1), H NMR (400 MHz, CDCl3) d =
1
8.22 (brs, 1 H), 7.99–7.96 (m, 2 H), 7.59 (dddd, 1 H, J = 7.3, 7.3,
1.3, 1.1 Hz), 7.50–7.45 (m, 3 H), 7.32–7.25 (m, 5 H), 7.11 (ddd, 1 H,
J = 8.1, 7.1, 1.3 Hz), 7.04 (ddd, 1 H, J = 8.1, 7.0, 1.1 Hz), 6.18–6.18
(m, 1 H), 4.92 (dd, 1 H, J = 7.9, 5.7 Hz), 3.90 (dd, 1 H, J = 17.6,
7.9 Hz), 3.65 (dd, 1 H, J = 17.6, 5.7 Hz). 13C NMR (100 MHz,
CDCl3) d = 198.3, 141.0, 140.2, 136.5, 136.1, 133.5, 132.8, 129.5,
128.8, 128.7, 128.1, 128.0, 121.6, 120.1, 119.7, 110.7, 100.0, 44.6,
39.0.; IR (CHCl3) 3464, 3020, 2401, 1686, 1597, 1521, 1490, 1456,
1418, 1340, 1300, 1209, 1092, 1015, 928, 731, 669 cm-1; MS (EI)
m/z 361 (M++2, 10), 359 (M+, 29), 256 (38), 255 (26), 254 (100),
237 (10), 236 (25), 111 (16), 105 (21), 77 (16); Found: C, 76.77;
H, 5.04; N, 3.89%. Calcd for C23H18ClNO: C, 76.94; H, 5.12; N,
3.85%; HPLC: Daicel Chiralpak AD-H, Hexane/iPrOH = 1/1.
Flow rate = 0.5 mL min-1, UV = 254 nm, tR = 14.1 min (minor),
tR = 17.7 min (major).
(S)-3-(1H-Indol-3-yl)-1-phenylbutan-1-one
(4m)18. Amor-
(S)-3-(4-Bromophenyl)-3-(1H-indol-2-yl)-1-phenylpropan-1-one
(7c). Mp 170–171 ◦C; [a]D26 -9.1 (c 0.99, CHCl3, 85% ee); Rf 0.35
(hexane: ethyl acetate = 5 : 1), H NMR (400 MHz, CDCl3) d =
phous, [a]2D6 -8.1 (c 1.2, CHCl3, 58% ee) (lit. (R)-isomer, [a]D25
+24.2 (c 0.4, CHCl3));18 Rf 0.20 (hexane: ethyl acetate = 5 : 1),
1H NMR (400 MHz, CDCl3) d = 7.97–7.94 (m, 3 H), 7.68 (dd,
1 H, J = 7.8, 1.0 Hz), 7.54 (dddd, 1 H, J = 7.4, 7.2, 1.4, 1.4 Hz),
7.46–7.41 (m, 2 H), 7.36 (ddd, 1 H, J = 8.0, 1.0, 1.0 Hz), 7.19
(ddd, 1 H, J = 8.0, 7.0, 1.2 Hz), 7.12 (ddd, 1 H, J = 7.0, 7.0,
1.0 Hz), 7.04–7.03 (m, 1 H), 3.83 (ddq, 1 H, J = 8.8, 4.9, 6.9 Hz),
3.48 (dd, 1 H, J = 16.4, 4.9 Hz), 3.24 (dd, 1 H, J = 16.4, 8.8 Hz),
1.45 (d, 3 H, J = 6.9 Hz); 13C NMR (100 MHz, CDCl3) d = 199.7,
137.3, 136.5, 132.9, 128.5, 128.1, 126.3, 122.0, 121.6, 120.2, 119.3,
119.2, 111.2, 46.4, 27.1, 21.0; HPLC: Daicel Chiralcel OD-H,
Hexane/EtOH = 5/1, Flow rate = 1.0 mL min-1, UV = 254 nm,
tR = 9.3 min (major), tR = 11.8 min (minor).
1
8.22 (brs, 1 H), 7.99–7.96 (m, 2 H), 7.59 (dddd, 1 H, J = 7.5, 7.3,
1.3, 1.3 Hz), 7.50–7.44 (m, 5 H), 7.27–7.22 (m, 3 H), 7.12 (ddd, 1 H,
J = 8.2, 7.0, 1.3 Hz), 7.05 (ddd, 1 H, J = 8.1, 7.0, 1.1 Hz), 6.18–6.18
(m, 1 H), 4.91 (dd, 1 H, J = 7.9, 5.7 Hz), 3.90 (dd, 1 H, J = 17.6,
7.9 Hz), 3.65 (dd, 1 H, J = 17.6, 5.7 Hz); 13C NMR (100 MHz,
CDCl3) d = 198.2, 141.3, 141.0, 136.6, 136.1, 133.6, 131.9, 129.9,
128.7, 128.1, 128.1, 121.7, 121.0, 120.1, 119.8, 110.7, 110.1, 44.7,
39.1; IR (CHCl3) 3686, 3618, 3464, 3020, 2401, 1684, 1597, 1521,
1489, 1420, 1340, 1217, 1074, 1045, 1013, 930, 731, 669 cm-1; MS
(EI) m/z 404 (M+, 25), 402 (M+, 27), 300 (18), 299 (98), 298 (100),
285 (17), 283 (19), 183 (13), 181 (13), 105 (16) 77 (15); Found:
C, 68.33; H, 4.49; N, 3.46%. Calcd for C23H18BrNO: C, 68.39; H,
4.31; N, 3.45%; Daicel Chiralpak AD-H, Hexane/iPrOH = 1/1.
Flow rate = 0.5 mL min-1, UV = 254 nm, tR = 15.5 min (minor),
tR = 20.6 min (major).
(S)-3-(1H-Indol-2-yl)-1,3-diphenylpropan-1-one (7a)11. To a
dry 20 mL flask under nitrogen were added phosphoric acid 3c
(14.0 mg, 0.02 mmol), chalcone 2a (62.5 mg, 0.3 mmol), and
toluene (1.0 mL). The solution was cooled to -78 ◦C, and 4,7-
5452 | Org. Biomol. Chem., 2010, 8, 5448–5454
This journal is
The Royal Society of Chemistry 2010
©